Trial Profile
Efficacy of sofosbuvir +/− simeprevir, analysed through TRIO health program, in real-world hepatitis C population
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2015
Price :
$35
*
At a glance
- Drugs Simeprevir (Primary) ; Sofosbuvir (Primary)
- Indications Hepatitis C
- Focus Therapeutic Use
- 11 Aug 2015 New trial record